Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on: March 22,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on:March 22,2024

Researchers develop innovative technique for distinguishing tumor from normal tissue

byMass General BrighamThe images show clusters of colorectal cancer cells metastasized to the liver, resected from a patient at Massachusetts General Hospital (MGH). The cells are visible as red

Updated on: January 06,2024

Researchers develop innovative technique for distinguishing tumor from normal tissue

byMass General BrighamThe images show clusters of colorectal cancer cells metastasized to the liver, resected from a patient at Massachusetts General Hospital (MGH). The cells are visible as red

Updated on:January 06,2024

Rituximab Maintenance Effective for Autoimmune Cytopenias

August 2023Thomas R. CollinsPatients with autoimmune cytopenias had longer durations of response after induction treatment with rituximab when rituximab was continued as maintenance therapy compared w

Updated on: February 18,2024

Rituximab Maintenance Effective for Autoimmune Cytopenias

August 2023Thomas R. CollinsPatients with autoimmune cytopenias had longer durations of response after induction treatment with rituximab when rituximab was continued as maintenance therapy compared w

Updated on:February 18,2024

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i

Updated on: December 22,2023

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i

Updated on:December 22,2023

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on: September 06,2024

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on:September 06,2024

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on: August 26,2024

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on:August 26,2024

Why are so many Australians taking antidepressants?

by Jon Jureidini,The ConversationCredit: Pixabay/CC0 Public DomainAroundone in seven Australianstake antidepressants; more than3.5 millionof us had them dispensed in 2021

Updated on: May 07,2024

Why are so many Australians taking antidepressants?

by Jon Jureidini,The ConversationCredit: Pixabay/CC0 Public DomainAroundone in seven Australianstake antidepressants; more than3.5 millionof us had them dispensed in 2021

Updated on:May 07,2024

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on: December 20,2023

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on:December 20,2023

Novel treatment shows promise against rare cancer in kids

by Carla K. JohnsonThis December 1993 microscope photo provided by the National Cancer Institute shows a typical neuroblastoma with rosette formation. In a study published Wednesday, April 5, 2023, in

Updated on: March 25,2024

Novel treatment shows promise against rare cancer in kids

by Carla K. JohnsonThis December 1993 microscope photo provided by the National Cancer Institute shows a typical neuroblastoma with rosette formation. In a study published Wednesday, April 5, 2023, in

Updated on:March 25,2024

New Study Uncovers Mechanisms Behind LKB1 Mutation-Driven Resistance to Immunotherapy in Lung Cancer

Updated on: July 17,2024

New Study Uncovers Mechanisms Behind LKB1 Mutation-Driven Resistance to Immunotherapy in Lung Cancer

Updated on:July 17,2024

Colon cancer: Dying cancer cells give neighboring tumor cells instructions on how to survive

by Markus Bernards,Goethe University Frankfurt am MainDying tumor cells induce mTOR survival signaling in a paracrine manner. Credit:Nature(2022). DOI: 10.1038/s41586-022-05426-1Colo

Updated on: December 26,2023

Colon cancer: Dying cancer cells give neighboring tumor cells instructions on how to survive

by Markus Bernards,Goethe University Frankfurt am MainDying tumor cells induce mTOR survival signaling in a paracrine manner. Credit:Nature(2022). DOI: 10.1038/s41586-022-05426-1Colo

Updated on:December 26,2023

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Updated on: July 11,2024

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Updated on:July 11,2024